Skip to content
MASI

MASIMO CORP

MASIMO CORP Q1 FY2024 earnings call

May 7, 2024 · fiscal period ended 2024-03

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-05-07

Management highlights

  • The business is back on track with healthcare revenues at the high end of guidance driven by strong sensor orders and record hospital contracting.
  • Sensor manufacturing moved to Malaysia ahead of schedule, improving gross margins.
  • Evaluating separation of consumer business, with preliminary financial impact estimate; potential spin-off or sale under consideration.
  • Increased healthcare revenue guidance, adjusted non-GAAP EPS, and projected consolidated revenue range from $2.055 billion to $2.165 billion.
  • Focus on gross margin expansion, targeting 30% operating margin long-term, with initiatives to reduce costs and increase efficiency.
View in transcript ↓

Segment performance

Healthcare: Revenue was $340 million, at the high end of guidance, representing a 2% decline vs last year. Non-GAAP gross margin in healthcare was 62%, up 110 basis points sequentially. Non-healthcare: Revenue was $153 million, midpoint of guidance, with a 29% decline on constant currency vs prior year. Non-GAAP gross margin in non-healthcare was 29%.

View in transcript ↓

Guidance

  • Consolidated revenue range: $2.055 billion to $2.165 billion.
  • Healthcare revenue: $1.355 billion to $1.385 billion (increased low end by $10 million).
  • Non-healthcare revenue: $700 million to $780 million (maintained).
  • Non-GAAP EPS: $3.54 to $3.70 (increased by $0.10 at both ends).
  • Second quarter guidance: Consolidated revenue $480 million to $510 million, non-GAAP operating profit $67 million to $72 million, non-GAAP EPS $0.73 to $0.79.
View in transcript ↓

Risks

  • Factors causing actual results to differ from projections, detailed in SEC filings.
  • Uncertainties in potential separation of consumer business, including timing and terms.
  • Macroeconomic conditions impacting non-healthcare business, like higher interest rates affecting consumer spending.
View in transcript ↓

Q&A highlights

Q: About drivers and step-up in subsequent quarters.

A: Micah explained slower replacement cycle post-COVID, expecting shipments to increase to 55,000 or more in Q2 and 60,000 or more in Q3/Q4.

Q: About second quarter guide.

A: Aligned with seasonality, confident in full-year guidance due to strong contracting.

Q: About Malaysia and gross margin.

A: Transition to Malaysia faster than expected, driving 60 basis point increase in guidance, long-term goal of 30% operating margin.

Q: About cash flow and separation impact.

A: Carve-out costs and litigation expenses affecting cash flow, expecting free cash flow to return.

Q: About separation timeline and strategic options.

A: Working on options, expect progress in next 30-45 days.

Q: About installed base and driver mix.

A: Minority of drivers are new, majority are replacements, true incremental contracts driving growth.

Q: About Malaysia transition impact.

A: Initial 60 basis point improvement, long-term potential for more efficiency and cost reduction.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

May 7, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.